Pick 2–10 funds, stocks or ETFs to see their returns, risk, costs and highlights on one page
* Fewer than 12 months: the year the fund started reporting NAV, or the current year
Counts only the top holdings with available data, not the whole portfolio · Pick a pair below for details
| 3069 | DAOL-CHINABIO | |
|---|---|---|
| Held by both | ||
| CSPC Pharmaceutical Group Ltd | 7.76% | 6.71% |
| JD Health International Inc | 7.38% | 6.39% |
| Sino Biopharmaceutical Ltd | 5.26% | 4.55% |
| Genscript Biotech Corp Class H | 3.72% | 3.22% |
 Wuxi AppTec Co Ltd | 3.70% | 3.20% |
| Only in 3069 | ||
| WuXi Biologics (Cayman) Inc | 11.33% | N/A |
| Innovent Biologics Inc | 5.65% | N/A |
| Alibaba Health Information Technology Ltd | 3.86% | N/A |
| Shandong Weigao Group Medical Polymer Co Ltd Class H | 3.31% | N/A |
| Only in DAOL-CHINABIO | ||
| WuXi Biologics | N/A | 9.80% |
| Innovent | N/A | 4.88% |
| Alibaba Health Information T… | N/A | 3.34% |
| Shandong Weigao Group Medica… | N/A | 2.86% |
29 Jan 2026 → 4 Nov 2026
| Fund | Return per year | Volatility per year | Sharpe |
|---|---|---|---|
| 3069 | −6.95% | 37.56% | −0.18 |
| DAOL-CHINABIO | −10.71% | 36.74% | −0.29 |
Sharpe here = annual return ÷ annual volatility, without deducting the risk-free rate, calculated from NAV over the selected period · Periods shorter than 1 year use the cumulative return instead of the annual return
| Drag a column header to reorder | 3069 | DAOL-CHINABIO |
|---|---|---|
Fund details | ||
| Fund size | N/A | 75.95 million |
| Inception date | N/A | 29 Jan 2026 |
| Master fund | N/A | Hang Seng Biotech Index ETF |
| Dividend policy | N/A | Does not pay |
Risk and currency hedging | ||
| Risk level | N/A | 7 |
| Hedging policy | N/A | Hedged at the manager's discretion |
| Share hedged | N/A | 73.46% |
Minimum purchase and redemption | ||
| First purchase | N/A | 1 THB |
| Subsequent purchase | N/A | 1 THB |
| Redemption (amount) | N/A | No minimum |
| Redemption (units) | N/A | No minimum |
| Balance (amount) | N/A | No minimum |
| Balance (units) | N/A | 100 units |
Order cut-off and redemption payment | ||
| Buy before | N/A | 13:30 |
| Redeem before | N/A | 13:30 |
| Redemption paid | N/A | T+3 |
